Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DBV Technologies SA - ADR - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
DBVT
Nasdaq
2834
https://www.dbv-technologies.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DBV Technologies SA - ADR
DBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call Transcript
- Mar 8th, 2024 4:01 pm
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
- Mar 8th, 2024 2:33 pm
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
- Mar 7th, 2024 9:30 pm
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
- Mar 4th, 2024 9:30 pm
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
- Feb 20th, 2024 9:30 pm
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
- Jan 16th, 2024 9:30 pm
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023
- Dec 4th, 2023 9:30 pm
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
- Nov 9th, 2023 9:30 pm
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
- Nov 6th, 2023 9:30 pm
DBV Technologies to Present New Data at ACAAI 2023
- Nov 2nd, 2023 8:30 pm
DBV Technologies S.A. (NASDAQ:DBVT) Q3 2023 Earnings Call Transcript
- Nov 1st, 2023 1:18 pm
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
- Oct 31st, 2023 8:30 pm
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
- Oct 27th, 2023 8:30 pm
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
- Oct 16th, 2023 6:00 am
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
- Oct 5th, 2023 8:30 pm
DBV Technologies to Participate in Upcoming Investor Conference
- Sep 5th, 2023 8:30 pm
DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
- Jul 31st, 2023 8:25 pm
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
- Jul 25th, 2023 8:30 pm
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
- Jul 19th, 2023 8:30 pm
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023
- Jun 16th, 2023 8:30 pm
Scroll